Correlation Between Kiniksa Pharmaceuticals and Day One
Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Day One.
Diversification Opportunities for Kiniksa Pharmaceuticals and Day One
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Kiniksa and Day is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Day One go up and down completely randomly.
Pair Corralation between Kiniksa Pharmaceuticals and Day One
Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to generate 0.85 times more return on investment than Day One. However, Kiniksa Pharmaceuticals is 1.18 times less risky than Day One. It trades about 0.03 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 1,812 in Kiniksa Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 154.00 from holding Kiniksa Pharmaceuticals or generate 8.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 99.6% |
| Values | Daily Returns |
Kiniksa Pharmaceuticals vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Kiniksa Pharmaceuticals |
| Day One Biopharmaceu |
Kiniksa Pharmaceuticals and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiniksa Pharmaceuticals and Day One
The main advantage of trading using opposite Kiniksa Pharmaceuticals and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |